As Congress Weighs TSCA Changes, US Chemical Regulation Hangs in the Balance

Why It Matters

The outcome will dictate whether the U.S. can maintain a competitive chemical industry while ensuring public health, and it will shape the EPA's capacity to enforce safety standards amid fiscal and legal pressures.

Key Takeaways

• Congress drafts limited TSCA updates, focusing on fee reauthorization
• EPA faces staffing gaps and a $17 M IT upgrade to modernize data
• Industry pushes for clearer “conditions of use” rules to speed approvals
• Courts now shape TSCA interpretation after Supreme Court ends Chevron deference
• Delays risk shifting US chemical production overseas, affecting competitiveness

Pulse Analysis

The Toxic Substances Control Act (TSCA) sits at a pivotal crossroads as lawmakers weigh incremental reforms. While the House and Senate are poised to renew the EPA's user‑fee program—critical funding that supports risk assessments and chemical reviews—their proposals stop short of a comprehensive overhaul. Industry stakeholders, represented by the American Chemistry Council, argue that clarifying "conditions of use" and streamlining data requirements would reduce review timelines, prevent costly offshoring of production, and bolster U.S. competitiveness in sectors ranging from AI‑driven materials to advanced manufacturing.

At the same time, the EPA confronts internal challenges that undermine its regulatory agenda. A recent $17 million congressional appropriation is earmarked for modernizing the agency's aging chemical‑data infrastructure, including a migration to cloud‑based platforms by 2028. Yet staffing volatility—evidenced by the loss of senior deputies—and the need to meet statutory deadlines for risk evaluations strain resources. The agency's shift toward incorporating real‑world exposure data aims to move away from worst‑case modeling, but inconsistent industry submissions and overlapping oversight from OSHA further complicate the process.

Legal dynamics add another layer of uncertainty. The Supreme Court's 2024 ruling in Loper Bright Enterprises v. Raimondo eliminated Chevron deference, empowering courts to interpret ambiguous TSCA language without deference to agency expertise. Ongoing litigation—spanning risk‑management rules for chemicals like trichloroethylene and carbon tetrachloride—means judicial outcomes could set precedents that either tighten or loosen regulatory thresholds. Consequently, the interplay of modest congressional tweaks, EPA operational reforms, and an increasingly activist judiciary will determine whether the United States can sustain robust chemical safety while fostering innovation.